NO20031743L - Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav - Google Patents

Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Info

Publication number
NO20031743L
NO20031743L NO20031743A NO20031743A NO20031743L NO 20031743 L NO20031743 L NO 20031743L NO 20031743 A NO20031743 A NO 20031743A NO 20031743 A NO20031743 A NO 20031743A NO 20031743 L NO20031743 L NO 20031743L
Authority
NO
Norway
Prior art keywords
venlafaxine
polyforms
novel
preparation
crystalline
Prior art date
Application number
NO20031743A
Other languages
English (en)
Other versions
NO20031743D0 (no
Inventor
Ben-Zion Dolitzky
Judith Aronhime
Shlomit Wizel
Gennady Nisnevish
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031743(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20031743D0 publication Critical patent/NO20031743D0/no
Publication of NO20031743L publication Critical patent/NO20031743L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031743A 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav NO20031743L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (2)

Publication Number Publication Date
NO20031743D0 NO20031743D0 (no) 2003-04-15
NO20031743L true NO20031743L (no) 2003-06-18

Family

ID=27500045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031743A NO20031743L (no) 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Country Status (20)

Country Link
US (1) US20020143211A1 (no)
EP (1) EP1334082A4 (no)
JP (2) JP2004530638A (no)
KR (1) KR20030059206A (no)
CN (1) CN1620420A (no)
AU (1) AU2002241764A1 (no)
CA (1) CA2426158A1 (no)
CZ (1) CZ20031298A3 (no)
DE (1) DE01988460T1 (no)
ES (1) ES2206082T1 (no)
HR (1) HRP20030392A2 (no)
HU (1) HUP0303496A3 (no)
IL (2) IL155400A0 (no)
IS (1) IS6789A (no)
MX (1) MXPA03003459A (no)
NO (1) NO20031743L (no)
PL (1) PL365895A1 (no)
SK (1) SK5762003A3 (no)
WO (1) WO2002045658A2 (no)
YU (1) YU30203A (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en) * 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
MXPA04005305A (es) * 2001-12-05 2004-09-13 Wyeth Corp Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo.
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AR039164A1 (es) 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
US6717015B2 (en) 2002-03-28 2004-04-06 Synthon Bv Venlafaxine besylate
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
DE10359154A1 (de) * 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006043577A1 (ja) * 2004-10-20 2006-04-27 Mitsubishi Pharma Corporation フェニルエタノールアミン化合物の製造方法及びその中間体
JP2009511641A (ja) * 2005-10-19 2009-03-19 テバ ファーマシューティカル インダストリーズ リミティド 高純度１−〔２−ジメチルアミノ−（４−メトキシフェニル）エチル〕シクロヘキサノール塩酸塩の調製方法
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
EP2032521B1 (en) 2006-06-27 2009-10-28 Sandoz AG New method for salt preparation
AR062064A1 (es) * 2006-07-14 2008-10-15 Medichem Sa Prcesos mejorados para preparar una base de venlafaxina y sus sales
CN103588653B (zh) * 2010-10-01 2015-04-22 山东绿叶制药有限公司 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用
CR20160222U (es) 2013-11-15 2016-08-26 Akebia Therapeutics Inc Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (no) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en) * 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
CZ20031298A3 (cs) 2003-10-15
CA2426158A1 (en) 2002-06-13
NO20031743D0 (no) 2003-04-15
AU2002241764A1 (en) 2002-06-18
EP1334082A4 (en) 2006-02-01
HUP0303496A3 (en) 2005-08-29
SK5762003A3 (en) 2003-11-04
WO2002045658A2 (en) 2002-06-13
ES2206082T1 (es) 2004-05-16
IL196287A0 (en) 2011-08-01
HUP0303496A2 (hu) 2004-01-28
JP2004530638A (ja) 2004-10-07
IL155400A0 (en) 2003-11-23
EP1334082A2 (en) 2003-08-13
IS6789A (is) 2003-04-15
PL365895A1 (en) 2005-01-10
JP2008239629A (ja) 2008-10-09
DE01988460T1 (de) 2004-04-22
KR20030059206A (ko) 2003-07-07
WO2002045658A3 (en) 2003-01-16
HRP20030392A2 (en) 2005-04-30
YU30203A (sh) 2006-08-17
US20020143211A1 (en) 2002-10-03
CN1620420A (zh) 2005-05-25
MXPA03003459A (es) 2005-04-29

Similar Documents

Publication Publication Date Title
NO20031743L (no) Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav
NO20042932L (no) En ny polymorf form av sertralin-hydroklorid og preparater som inneholder denne, samt nye fremgangsmater for fremstilling av polymorfe former og en amorf form av sertralinhydroklorid
NO20005454D0 (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmÕte for fremstilling derav
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
DK1373224T3 (da) Nye spirotricykliske derivater og deres anvendelse som phosphodiesterase 7 inhibitorer
NO20040680L (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
IL162253A0 (en) Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
IL149222A0 (en) Stable polymorph of n-(3-ethynlamino)-6,7-bis (2-metoxyethoxy)- 4-quinaolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
NO20015113D0 (no) Nye forbindelser, deres fremstilling og anvendelse
IL164588A0 (en) ogenitor cells Novel methods for the invitro identification, isolation and differention of vasculogenic progenic pr
NO20005266D0 (no) Nye substituerte amider, deres fremstilling og anvendelse
ITUD20000163A0 (it) Dispositivo per la produzione di manufatti poliuretanici, relativo procedimento e manufatti poliuretanici cosi' ottenuti
AP2004002989A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
IS7289A (is) Kristallaður venlafaxínbasi og nýir fjölgervingarvenlafaxínhýdróklóríðs, aðferðir til að framleiðaþá
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1098891T3 (da) Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
NO975220D0 (no) Ny fremgangsmåte for fremstilling av ropivacainhydrokloridmonohydrat
IL159266A0 (en) Crystalline forms of fexofenadine and processes for the preparation thereof
ZA200405245B (en) Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1265856T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af alpha-(2,4-disulfophenyl)-N-tert-butylnitron og farmaceutisk acceptable salte deraf
NO20014077L (no) Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application